Followers | 21 |
Posts | 1791 |
Boards Moderated | 0 |
Alias Born | 03/07/2014 |
Thursday, December 14, 2023 11:50:37 AM
"Following the FDA approval of LYFGENIA on December 8, 2023 for sickle cell disease in patients 12 and older with a history of vaso-occlusive
events, bluebird bio, Inc. (the “Company”) has signed an outcomes-based agreement with an organization representing approximately 100 million covered
lives in the U.S. Additionally, the Company is in advanced discussions with a number of the nation’s other large commercial payers and more than 15
Medicaid agencies collectively representing 80% of individuals with sickle cell disease in the U.S. The Company anticipates 85 to 105 patient starts (cell
collections) combined across all three of its commercial products (LYFGENIA, ZYNTEGLO, SKYSONA) in 2024."
https://investor.bluebirdbio.com/static-files/a9da7005-b393-4e1b-bf28-71850b6a47a8
Recent BLUE News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:05:45 PM
- Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 05/14/2024 09:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:01:50 AM
- bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance • Business Wire • 05/09/2024 11:00:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUE • PR Newswire (US) • 05/07/2024 09:45:00 AM
- bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events • Business Wire • 05/06/2024 11:05:00 AM
- bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy • Business Wire • 05/06/2024 11:00:00 AM
- Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 05/03/2024 09:45:00 AM
- bluebird bio Announces Receipt of Expected Notice from Nasdaq • Business Wire • 04/26/2024 08:05:00 PM
- The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 04/26/2024 09:45:00 AM
- bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUE • PR Newswire (US) • 04/19/2024 09:45:00 AM
- Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 04/12/2024 09:45:00 AM
- bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/11/2024 12:00:00 PM
- bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUE • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Shareholders that lost money on bluebird bio, Inc.(BLUE) should contact The Gross Law Firm about pending Class Action - BLUE • PR Newswire (US) • 04/05/2024 09:45:00 AM
- bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance • Business Wire • 03/26/2024 11:01:00 AM
- bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call • Business Wire • 03/25/2024 08:05:00 PM
- bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital • Business Wire • 03/18/2024 12:00:00 PM
- bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy • Business Wire • 03/11/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:40:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:40:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:40:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:39:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:39:41 PM
FEATURED Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM
Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • BLEG • May 15, 2024 8:30 AM
Alliance Creative Group (ACGX) Releases Q1 2024 Financial and Disclosure Report with an 88% increase in Net Income from Q1 2023 to Q1 2024 • ACGX • May 15, 2024 8:30 AM
Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • CATV • May 15, 2024 8:00 AM
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • POET • May 14, 2024 10:09 AM